These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 2122594)

  • 1. [The use of holoxan (iphosphamide) in malignant tumors].
    Perevodchikova NI; Orel NF; Trofimova NV
    Vopr Onkol; 1990; 36(9):1085-8. PubMed ID: 2122594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Responses of 109 adult soft tissue sarcoma patients to chemotherapy].
    Qiu MZ; Xu F; Wang SS; Luo HY; Wang F; Li FH; Sun XF; Xu GC; Lin TY; Huang HQ; Jiang WQ; Guan ZZ; Xu RH
    Ai Zheng; 2007 Dec; 26(12):1344-9. PubMed ID: 18076798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ifosfamide in the treatment of soft-tissue sarcomas: experience at the West German Tumor Center, Essen.
    Schütte J; Kellner R; Seeber S
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S194-8. PubMed ID: 8453697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of advanced malignancies with ifosfamide under protection with mesna.
    Li GC; Brock N; Li JQ; Guan ZZ; He YJ
    Int J Clin Pharmacol Res; 1988; 8(1):55-67. PubMed ID: 3130316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of advanced soft tissue sarcomas with ifosfamide and doxorubicin combination chemotherapy.
    Barişta I; Tekuzman G; Yalçin S; Güllü I; Güler N; Ozişik Y; Kars A; Celik I; Türker A; Altundağ K; Zengin N; Uner A; Baltali E; Firat D
    J Surg Oncol; 2000 Jan; 73(1):12-6. PubMed ID: 10649272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical studies of ifosfamide/mesna at St Jude Children's Research Hospital, 1983-1988.
    Pratt CB; Douglass EC; Etcubanas E; Goren MP; Green AA; Hayes FA; Horowitz ME; Meyer WH; Thompson EI; Wilimas JA
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):51-5. PubMed ID: 2495567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ifosfamide combination regimens for soft-tissue sarcoma.
    Stuart-Harris R; Dalley D; Bell DR; Levi J; Simes RJ; Wiltshaw E
    Cancer Chemother Pharmacol; 1993; 31 Suppl 2():S185-8. PubMed ID: 8453695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Southwest Oncology Group and Cancer and Leukemia Group B phase II study of doxorubicin, dacarbazine, ifosfamide, and mesna in adults with advanced osteosarcoma, Ewing's sarcoma, and rhabdomyosarcoma.
    Antman K; Crowley J; Balcerzak SP; Kempf RA; Weiss RB; Clamon GH; Baker LH
    Cancer; 1998 Apr; 82(7):1288-95. PubMed ID: 9529020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase 2 trial of ifosfamide/mesna as salvage therapy in patients with ovarian cancer refractory to or relapsing after prior platinum-containing chemotherapy.
    Sørensen P; Pfeiffer P; Bertelsen K
    Gynecol Oncol; 1995 Jan; 56(1):75-8. PubMed ID: 7821851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of ifosfamide in the treatment of adult soft tissue sarcomas, Ewing's sarcoma, and osteosarcoma: a review.
    Dirix LY; Van Oosterom AT
    Semin Oncol; 1990 Apr; 17(2 Suppl 4):50-7. PubMed ID: 2185547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ifosfamide in non-small cell lung cancer.
    Johnson DH
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):7-10. PubMed ID: 8677453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase II trial of ifosfamide with mesna in previously treated metastatic sarcoma.
    Antman KH; Montella D; Rosenbaum C; Schwen M
    Cancer Treat Rep; 1985 May; 69(5):499-504. PubMed ID: 3924401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ifosfamide in the treatment of soft tissue sarcomas.
    Connelly EF; Budd GT
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):16-21. PubMed ID: 8677442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ongoing clinical studies of ifosfamide for pediatric cancer in the United States.
    Pratt CB
    Semin Oncol; 1996 Jun; 23(3 Suppl 6):84-90. PubMed ID: 8677456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preliminary result of advanced soft tissue sarcoma treated by MAID regimen].
    Huang YH; Wen XP; Hu L
    Ai Zheng; 2002 Aug; 21(8):907-9. PubMed ID: 12478905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proceedings of a symposium on ifosfamide (Mitoxana; Holoxan) and Mesna (Uromitexan). Coventry, U.K., 16-18 March 1983.
    Cancer Treat Rev; 1983 Sep; 10 Suppl A():1-192. PubMed ID: 6414687
    [No Abstract]   [Full Text] [Related]  

  • 17. Ifosfamide in pediatric malignancies.
    Jürgens H; Treuner J; Winkler K; Göbel U
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):46-50. PubMed ID: 2649985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of ifosfamide in the treatment of sarcomas.
    Dirix LY; Van Oosterom AT
    Semin Oncol; 1989 Feb; 16(1 Suppl 3):39-45. PubMed ID: 2649984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of ifosfamide/mesna in metastatic adult renal carcinoma.
    De Forges A; Droz JP; Ghosn M; Theodore C
    Cancer Treat Rep; 1987 Nov; 71(11):1103. PubMed ID: 3119203
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase III trial of two investigational schedules of ifosfamide compared with standard-dose doxorubicin in advanced or metastatic soft tissue sarcoma: a European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study.
    Lorigan P; Verweij J; Papai Z; Rodenhuis S; Le Cesne A; Leahy MG; Radford JA; Van Glabbeke MM; Kirkpatrick A; Hogendoorn PC; Blay JY;
    J Clin Oncol; 2007 Jul; 25(21):3144-50. PubMed ID: 17634494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.